Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference
31 Julio 2024 - 3:01PM
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik
Holmlin, PhD, Bionano’s president and chief executive officer, will
present at the Canaccord Genuity 44th Annual Growth Conference on
August 13, 2024.
Conference & Webcast Details
Date: |
August 13, 2024 |
Time: |
3:30 p.m. to 3:55 p.m. ET |
Presenter: |
Erik Holmlin, PhD, CEO of Bionano |
Webcast: |
Link to Register |
A replay / recording of the session will be available following
the conference through the Bionano website
at https://ir.bionano.com/ for at least 30 days.
About Bionano
Bionano is a provider of genome analysis solutions that can
enable researchers and clinicians to reveal answers to challenging
questions in biology and medicine. The Company’s mission is to
transform the way the world sees the genome through OGM solutions,
diagnostic services and software. The Company offers OGM solutions
for applications across basic, translational and clinical research.
The Company also offers an industry-leading, platform-agnostic
genome analysis software solution and nucleic acid extraction and
purification solutions using proprietary isotachophoresis (ITP)
technology. Through its Lineagen, Inc. d/b/a Bionano Laboratories
business, the Company also offers OGM-based diagnostic testing
services.
For more information, visit http://www.bionano.com or
www.bionanolaboratories.com.
Bionano’s OGM products are for research use only and not for use
in diagnostic procedures.
CONTACTS
Company Contact:Erik Holmlin, CEOBionano
Genomics, Inc.+1 (858) 888-7610eholmlin@bionano.com
Investor Relations:David HolmesGilmartin
Group+1 (858) 888-7625IR@bionano.com
Bionano Genomics (NASDAQ:BNGO)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Bionano Genomics (NASDAQ:BNGO)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024